Newer Strategies for the Management of Low-Grade Gliomas

Karan Singh Dixit, Jeffrey Raizer

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Low-grade gliomas are infiltrative primary brain tumors that most commonly occur in young adults. They are relatively slow growing compared with high-grade gliomas. The World Health Organization classification system was updated in 2016 to define low-grade gliomas using molecular markers in addition to histology. IDH mutation is an independent marker associated with better outcomes. Management is individualized based on tumor histology, molecular characterization, and patient risk factors. Given the longer course and natural history of low-grade gliomas, the goals of treatment should be to prolong overall survival and minimize neurocognitive decline. Early maximum safe resection is the first line of treatment. While low-risk patients may be followed with observation after surgery, patients with high-risk factors (subtotal resection, age > 40 years, IDH wild-type tumors) should be treated with radiation and chemotherapy. Improved understanding of the molecular characteristics of low-grade gliomas will further guide risk stratification and allow the identification of treatment approaches that are more effective and less toxic.

Original languageEnglish (US)
JournalOncology (Williston Park, N.Y.)
Volume31
Issue number9
StatePublished - Sep 15 2017

Fingerprint

Glioma
Histology
Poisons
Natural History
Brain Neoplasms
Young Adult
Neoplasms
Therapeutics
Observation
Radiation
Drug Therapy
Mutation
Survival

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

@article{1822860117b9478bbddadce40a5e415a,
title = "Newer Strategies for the Management of Low-Grade Gliomas",
abstract = "Low-grade gliomas are infiltrative primary brain tumors that most commonly occur in young adults. They are relatively slow growing compared with high-grade gliomas. The World Health Organization classification system was updated in 2016 to define low-grade gliomas using molecular markers in addition to histology. IDH mutation is an independent marker associated with better outcomes. Management is individualized based on tumor histology, molecular characterization, and patient risk factors. Given the longer course and natural history of low-grade gliomas, the goals of treatment should be to prolong overall survival and minimize neurocognitive decline. Early maximum safe resection is the first line of treatment. While low-risk patients may be followed with observation after surgery, patients with high-risk factors (subtotal resection, age > 40 years, IDH wild-type tumors) should be treated with radiation and chemotherapy. Improved understanding of the molecular characteristics of low-grade gliomas will further guide risk stratification and allow the identification of treatment approaches that are more effective and less toxic.",
author = "Dixit, {Karan Singh} and Jeffrey Raizer",
year = "2017",
month = "9",
day = "15",
language = "English (US)",
volume = "31",
journal = "Oncology",
issn = "0890-9091",
publisher = "UBM Medica Healthcare Publications",
number = "9",

}

Newer Strategies for the Management of Low-Grade Gliomas. / Dixit, Karan Singh; Raizer, Jeffrey.

In: Oncology (Williston Park, N.Y.), Vol. 31, No. 9, 15.09.2017.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Newer Strategies for the Management of Low-Grade Gliomas

AU - Dixit, Karan Singh

AU - Raizer, Jeffrey

PY - 2017/9/15

Y1 - 2017/9/15

N2 - Low-grade gliomas are infiltrative primary brain tumors that most commonly occur in young adults. They are relatively slow growing compared with high-grade gliomas. The World Health Organization classification system was updated in 2016 to define low-grade gliomas using molecular markers in addition to histology. IDH mutation is an independent marker associated with better outcomes. Management is individualized based on tumor histology, molecular characterization, and patient risk factors. Given the longer course and natural history of low-grade gliomas, the goals of treatment should be to prolong overall survival and minimize neurocognitive decline. Early maximum safe resection is the first line of treatment. While low-risk patients may be followed with observation after surgery, patients with high-risk factors (subtotal resection, age > 40 years, IDH wild-type tumors) should be treated with radiation and chemotherapy. Improved understanding of the molecular characteristics of low-grade gliomas will further guide risk stratification and allow the identification of treatment approaches that are more effective and less toxic.

AB - Low-grade gliomas are infiltrative primary brain tumors that most commonly occur in young adults. They are relatively slow growing compared with high-grade gliomas. The World Health Organization classification system was updated in 2016 to define low-grade gliomas using molecular markers in addition to histology. IDH mutation is an independent marker associated with better outcomes. Management is individualized based on tumor histology, molecular characterization, and patient risk factors. Given the longer course and natural history of low-grade gliomas, the goals of treatment should be to prolong overall survival and minimize neurocognitive decline. Early maximum safe resection is the first line of treatment. While low-risk patients may be followed with observation after surgery, patients with high-risk factors (subtotal resection, age > 40 years, IDH wild-type tumors) should be treated with radiation and chemotherapy. Improved understanding of the molecular characteristics of low-grade gliomas will further guide risk stratification and allow the identification of treatment approaches that are more effective and less toxic.

UR - http://www.scopus.com/inward/record.url?scp=85049262461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049262461&partnerID=8YFLogxK

M3 - Article

C2 - 29071695

AN - SCOPUS:85049262461

VL - 31

JO - Oncology

JF - Oncology

SN - 0890-9091

IS - 9

ER -